Virginia is accusing some of the largest names in the prescription drug industry of artificially inflating the prices of insulin, a life-saving medication, over the course of several years.
The commonwealth claims that pharmacy benefit managers and drug manufacturers are in cahoots to inflate insulin prices for ...
PBMs are pivoting reimbursement models to protect pharmacies from what they say is an unsustainable status quo.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback